Prof John Zajicek:
Chair in Medicine

Research Overview:

Professor John Zajicek trained in Medicine at Cambridge and St Mary’s Hospital in London. He completed a PhD in cell biology in Cambridge, moved to Plymouth in 1995 as a Consultant Neurologist, and took up the Chair of Clinical Neuroscience at Plymouth University. In Plymouth he was Director of the Peninsula Clinical Trials Unit, and Chair of the UK NIHR Nervous System Disorders Specialty Group. He has recently moved to the University of St Andrews, where he is Professor of Medicine. Zajicek has served on the UK MRC Neuroscience and Mental Health Board and the MRC Methodology Panel. He is particularly interested in the way we do trials for neurodegenerative diseases, has been Chief Investigator in several large multicentre randomized controlled trials, including the investigation of cannabinoid use to slow neurodegeneration. He has authored many papers on cannabinoids, multiple sclerosis and the methodology of clinical trials in neurodegeneration, including Alzheimer’s and Parkinson’s diseases.


5 (of 97 published available) for jz45 (source: University of St Andrews PURE)
Please click title of any item for full details

Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS) Jennifer A Freeman, Wendy Hendrie, Louise Jarrett, Annie Hawton, Andrew Barton, Rachel Dennett, Benjamin Jones, John Peter Zajicek, Siobhan Creanor
Lancet Neurology vol.18 pp.736-747
Improving the quality of cognitive screening assessments C. G. . Newman, A. Bevins, John Peter Zajicek, J. Hodges, E. Vuillermoz, J. Dickenson, D. Kelly, S. Brown, R. Noad
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2018 vol.10 pp.182-187
Machine-learning based identification of undiagnosed dementia in primary care Emmanuel A. Jammeh, Camille B. Carroll, Stephen W. Pearson, Javier Escudero, Athanasios Anastasiou, Peng Zhao, Todd Chenore, John Peter Zajicek, Emmanuel Ifeachor
BJGP Open 2018 vol.2
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis H. Gunn, J. Andrade, L. Paul, L. Miller, S. Creanor, C. Green, J. Marsden, P. Ewings, M. Berrow, J Vickery, A. Barton, B. Marshall, John Peter Zajicek, J. A. Freeman
Pilot and Feasibility Studies 2017 vol.4
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease David J. M. McGhee, Craig W. Ritchie, John Peter Zajicek, Carl E. Counsell
BMC Neurology 2016 vol.16 pp.1-13